CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neutral
AI Analysis

Summary

Nektar Therapeutics granted non-qualified stock options to purchase 36,000 shares of common stock as inducement grants under Nasdaq Listing Rule 5635(c)(4) on July 20, 2026.

Importance:2/10
Sentiment:
0.00
stock optionsinducement grantscompensationnasdaq rule 5635
Related Companies

Read the original article

Published by PR Newswire Biotech on July 24, 2026 8:15 PM

Read Original